Yield10 Bioscience
Stock Forecast, Prediction & Price Target

Yield10 Bioscience Financial Estimates

Yield10 Bioscience Revenue Estimates

Yield10 Bioscience EBITDA Estimates

Yield10 Bioscience Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026 12/31/2027
Revenue
 
% change YoY
$614K
 
N/A
$450K
 
-26.71%
$60K
 
-86.66%
Avg: $2.6M
Low: $1.2M
High: $3.99M
avg. 4233.33%
Avg: $26.75M
Low: $21.51M
High: $31.98M
avg. 928.84%
Avg: $47.15M
Low: $37.91M
High: $56.38M
avg. 76.26%
Net Income
 
% change YoY
$-11.03M
 
N/A
$-13.56M
 
-22.98%
$-14.45M
 
-6.55%
Avg: $-11.62M
Low: $-6.75M
High: $-913.82K
avg. 19.60%
Avg: $-6.00M
Low: $-58.15K
High: $-34.55K
avg. 48.33%
Avg: $397.31K
Low: $296.18K
High: $498.44K
avg. 106.61%
EBITDA
 
% change YoY
$-12.17M
 
N/A
$-13.18M
 
-8.34%
$-14.12M
 
-7.12%
Avg: $-2.6M
Low: $-3.99M
High: $-1.2M
avg. 81.59%
Avg: $-26.75M
Low: $-31.98M
High: $-21.51M
avg. -928.84%
Avg: $-47.15M
Low: $-56.38M
High: $-37.91M
avg. -76.26%
EPS
 
% change YoY
-$55.95
 
N/A
-$66.25
 
-18.40%
-$43.66
 
34.09%
Avg: -$11.58
Low: -$20.4
High: -$2.76
avg. 73.47%
Avg: -$0.14
Low: -$0.18
High: -$0.1
avg. 98.79%
Avg: $1.2
Low: $0.89
High: $1.51
avg. 957.14%
Operating Expenses
 
% change YoY
$12.30M
 
N/A
$13.90M
 
12.96%
$14.47M
 
4.14%
Avg: $69.32M
Low: $31.99M
High: $106.64M
avg. 378.84%
Avg: $713.21M
Low: $573.56M
High: $852.87M
avg. 928.84%
Avg: $1.25B
Low: $1.01B
High: $1.50B
avg. 76.26%

FAQ

What is Yield10 Bioscience stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 58.18% in 2025-2027.

We have gathered data from 2 analysts. Their low estimate is -6.75M, average is -11.62M and high is -913.82K.

What is Yield10 Bioscience stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 1746.14% in 2025-2027.

We have gathered data from 2 analysts. Their low revenue estimate is $1.2M, average is $2.6M and high is $3.99M.

What is Yield10 Bioscience stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 376.47% in 2025-2027.

We have gathered data from 2 analysts. Their low earnings per share estimate is -$20.4, average is -$11.58 and high is $-2.76.

What is the best performing analyst?

In the last twelve months analysts have been covering Yield10 Bioscience stock. The most successful analyst is Ben Klieve whose win rate is 100%. He has correctly predicted 1/1 price targets.